{"id":"W4411159569","doi":"10.1002/bcp.70118","title":"Exposure–response relationship of fedratinib in patients with intermediate‐2 or high‐risk myelofibrosis","year":2025,"lang":"en","type":"article","venue":"British Journal of Clinical Pharmacology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada","keywords":"Medicine; Ruxolitinib; Internal medicine; Confidence interval; Myelofibrosis; Anemia; Gastroenterology; Adverse effect; Population; Odds ratio; Nausea; Incidence (geometry); Janus kinase inhibitor; Bone marrow; Tofacitinib","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005637649,0.0003071756,0.0008910355,0.000466022,0.0001267884,0.0006509815,0.0002227007,0.0003829605,0.001425042],"category_scores_gemma":[0.005900423,0.0002299066,0.002491557,0.0005236217,0.000150791,0.000543998,0.0003526193,0.0007539223,0.000133026],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002837673,"about_ca_system_score_gemma":0.0002133391,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002944098,"about_ca_topic_score_gemma":0.0005039121,"domain_scores_codex":[0.9975076,0.001356871,0.0002930496,0.0004214802,0.000280975,0.0001400308],"domain_scores_gemma":[0.9941922,0.003299758,0.001678028,0.000407545,0.0002643841,0.0001580407],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.05423665,0.0005082756,0.8472345,0.0007668413,0.01707171,0.0002688449,0.0001493816,0.003165958,0.004166536,0.0002141316,0.0006753237,0.07154191],"study_design_scores_gemma":[0.001299645,0.009674869,0.9700577,0.00008147261,0.007274881,0.0008194089,0.00009774495,0.005837664,0.002348636,0.0004116782,0.002055296,0.00004114986],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9913351,0.006069079,0.001223597,0.00009931281,0.00001500885,0.00003957634,0.0004715736,0.00002332772,0.0007234862],"genre_scores_gemma":[0.9990089,0.0002672923,0.0002050494,0.00005810679,0.00001945263,0.00001512331,0.00031016,0.000002690962,0.0001132766],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005637649,"threshold_uncertainty_score":0.02981508,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02714855916514814,"score_gpt":0.3787313259327033,"score_spread":0.3515827667675552,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}